Clinical Trial Update: Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa

View source ↗

Summary

This clinical trial update reports results on managing gastrointestinal and genitourinary bleeding in atrial fibrillation patients treated with Pradaxa (dabigat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2017-01-31